Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Urologix says it will lay off an unspecified number of employees in a restructuring move designed to save more than $1.5 million a year.
Massachusetts-based Ocular Therapeutix wins FDA premarket approval for its ReSure sealant for preventing wound leaks in eye surgery incisions.
Medtronic suspends its worldwide renal denervation trials after the U.S. pivotal trial of its Symplicity device fails to meet its efficacy endpoint.